CARE Ratings Limited has informed the Exchange regarding Change in Director(s) of the company.
CARERATING · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
CARE Ratings' Board, at its meeting on August 5, 2025, approved unaudited standalone and consolidated financial results for Q1 FY26 (quarter ended June 30, 2025). On a consolidated basis, revenue from operations rose to ₹9,390.50 lakhs from ₹7,892.00 lakhs in Q1 FY25 (about 19% YoY growth), while net profit grew to ₹2,649.74 lakhs from ₹2,138.29 lakhs (~24% YoY growth). Standalone net profit stood at ₹2,911.55 lakhs versus ₹2,401.16 lakhs a year ago. The Board also approved the reappointment of two Independent Directors: Mr. G. Mahalingam (former RBI and SEBI Whole-time Member) for three years effective November 21, 2025, and Mr. V. Chandrasekaran (current Chairman, ex-LIC Executive Director) for three years effective December 7, 2025, both subject to shareholder approval. Limited review was carried out by B S R & Co. LLP with an unmodified conclusion.
Strong YoY growth in both revenue and profit signals healthy operational momentum for the credit rating agency. The reappointment of two experienced Independent Directors supports board continuity and governance stability, which is generally viewed positively by shareholders.